Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Foghorn Therapeutics (FHTX) Tax Provisions (2023)

Historic Tax Provisions for Foghorn Therapeutics (FHTX) over the last 1 years, with Q4 2023 value amounting to $2.0 million.

  • Foghorn Therapeutics' Tax Provisions changed N/A to $2.0 million in Q4 2023 from the same period last year, while for Sep 2024 it was $2.0 million, marking a year-over-year decrease of 1133.93%. This contributed to the annual value of $4.2 million for FY2023, which is N/A changed from last year.
  • According to the latest figures from Q4 2023, Foghorn Therapeutics' Tax Provisions is $2.0 million.
  • In the past 5 years, Foghorn Therapeutics' Tax Provisions ranged from a high of $2.0 million in Q4 2023 and a low of $560000.0 during Q1 2023